Latest Regulatory Milestones News

Imricor Medical Systems has secured A$60 million through a placement to fund its US commercial rollout, regulatory approvals, and clinical programs, boosting its cash reserves to nearly A$103 million.

PMET Resources has produced 4.47 tonnes of 6.09% Li2O spodumene concentrate at 89% recovery from its CV5 Pegmatite using an innovative DMS pilot program, bolstering its lithium project development and upcoming feasibility updates.

Energy Transition Minerals has released a JORC-compliant Mineral Resource Estimate for its Penouta tin-tantalum-niobium mine in Spain, reinforcing its strategic role in Europe's critical minerals supply chain and setting the stage for a project restart.

Magnetic Resources NL has reported significant new drilling results at its Lady Julie North 4 deposit, confirming multiple thick, high-grade gold zones and extending mineralisation down to 640m, with the resource remaining open at depth.

Brazilian Critical Minerals (ASX: BCM) has locked in pre-approval under Australia’s R&D Tax Incentive for its Ema Rare Earth Project, including critical overseas activities in Brazil. This reduces regulatory uncertainty and supports funding efficiency for advancing the project’s development.

LTR Pharma highlights SPONTAN's 5x faster absorption and validated safety, backed by over 1,000 Australian prescriptions and strategic partnerships as it targets FDA approval and US market entry.

Sinowin Lithium, MRG Metals’ JV partner, will fund drilling at Corridor North in Mozambique, extending its investment beyond the 2 billion tonne Corridor Central and South projects targeting 2027 production and a ramp-up to 800,000 tonnes per annum.

RareX Limited has advanced its rare earths ambitions by securing a key mining lease at Cummins Range, appointing a strategic board member, and raising $5 million to fund exploration and development.

Comet Ridge progresses engineering design and environmental approvals for its Mahalo Gas Project, pushing ahead with the acquisition of Santos’ stake to consolidate full ownership and expand its east coast gas footprint.

ABx Group has made significant strides in its rare earths and clean fluorine chemical projects, receiving high-purity product validation and advancing pilot plant construction, while progressing bauxite mining approvals across multiple states.

Alterity Therapeutics secures FDA backing on key Phase 3 elements for ATH434 in Multiple System Atrophy, bolstered by fresh Phase 2 data showing slowed disease progression and strategic leadership hires.

Boab Metals has secured a A$236 million syndicated loan and final regulatory approvals, accelerating construction at its Sorby Hills Silver-Lead-Zinc Project with production on track for H2 2027.